Amount Raised
$105 Million
Round Type
IPO
New YorkOtherBiotechnologyHealth CareTherapeuticsInvestors
Description
On June 30, 2026, Neurogene Inc. completed an underwriting agreement to sell 3,500,000 shares of its common stock at a public offering price of $30.00 per share. Additionally, pre-funded warrants for 666,666 shares were included in the offering for certain investors. This funding will support the company's initiatives in gene therapy development
Quick answer
Neurogene raised $105 Million in a IPO round, dated March 18, 2024. Investors: Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated and Leerink Partners LLC. Neurogene is based in New York, New York, United States.
- How much did Neurogene raise?
- Neurogene raised $105 Million in a IPO round on March 18, 2024.
- Who invested in Neurogene?
- Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated and Leerink Partners LLC are named as investors in this round.
- What does Neurogene do?
- Neurogene Inc. is a clinical-stage company dedicated to bringing life-changing genetic medicines to patients and families affected by rare neurological diseases.
- Where is Neurogene based and how big is it?
- Neurogene is based in New York, New York, United States. Fundz records about 110 employees.
- Who are the decision-makers at Neurogene?
- Fundz holds 2 contacts at Neurogene, including the Senior Vice President, Technical Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Neurogene that raised within 45 days of this round, from Fundz verified event records.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
- Cerevance raised $47M (Series B) on April 29, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
Who to call at Neurogene, and when
A new round usually means Neurogene is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neurogene raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurogene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurogene. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurogene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Neurogene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.